Daniel Adlerstein

Daniel Adlerstein has an extensive background in the field of molecular diagnostics and assay development. Daniel has held various directorial roles in companies such as QIAGEN, Atlas Genetics Ltd, and Biotrin International. Currently, Daniel serves as a Trainee European Patent Attorney at Modiano & Partners. Daniel's expertise lies in the development of novel technologies and assays, including fluorescent isothermal amplification and Q-LAMP based assays.他的经验范围包括从头开发新技术到市场推广新产品。